Cytosorbents (CTSO) Shares Outstanding (Entity) (2010 - 2026)
Cytosorbents (CTSO) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 2.00 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 383.36 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.49 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 660.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 412.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 1.11 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | 62.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.73 Mn |
| Dec 31, 2025 | 62.80 Mn |
| Sep 30, 2025 | 62.79 Mn |
| Jun 30, 2025 | 62.61 Mn |
| Mar 31, 2025 | 62.53 Mn |
| Dec 31, 2024 | 54.83 Mn |
| Sep 30, 2024 | 54.50 Mn |
| Jun 30, 2024 | 54.31 Mn |
| Mar 31, 2024 | 54.29 Mn |
| Dec 31, 2023 | 44.66 Mn |
| Sep 30, 2023 | 44.44 Mn |
| Jun 30, 2023 | 44.19 Mn |
| Mar 31, 2023 | 43.85 Mn |
| Dec 31, 2022 | 43.48 Mn |
| Sep 30, 2022 | 43.63 Mn |
| Jun 30, 2022 | 43.57 Mn |
| Mar 31, 2022 | 43.51 Mn |
| Dec 31, 2021 | 43.48 Mn |
| Sep 30, 2021 | 43.48 Mn |
| Jun 30, 2021 | 43.34 Mn |